These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Chloro-substituted, sterically hindered 5,11-dicarbo analogues of clozapine as potential chiral antipsychotic agents. Davis DA; de Paulis T; Janowsky A; Smith HE J Med Chem; 1990 Feb; 33(2):809-14. PubMed ID: 1967652 [TBL] [Abstract][Full Text] [Related]
7. The toxicology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine (clozapine). Lindt S; Lauener H; Eichenberger E Farmaco Prat; 1971 Oct; 26(10):585-602. PubMed ID: 5157542 [No Abstract] [Full Text] [Related]
8. [Synthesis and neurologic action of new 11-substituted 5H-dibenzo[b,e][1,4]diazepines]. Skoldinov AP; Rayevskii KS; Likhosherstov AM; Stavrovskaja AW; Rüger C; Rostock A; Röhnert H Pharmazie; 1984 Dec; 39(12):812-3. PubMed ID: 6543394 [TBL] [Abstract][Full Text] [Related]
9. Effects of clozapine and other dibenzo-epines on central dopaminergic and cholinergic systems. Structure-activity relationships. Bürki HR; Sayers AC; Ruch W; Asper H Arzneimittelforschung; 1977; 27(8):1561-5. PubMed ID: 20900 [TBL] [Abstract][Full Text] [Related]
10. 6-(4-Methyl-1-piperazinyl)morphanthridine (Perlapine), a new tricyclic compound with sedative and sleep-promoting properties. A pharmacological study. Stille G; Sayers A; Lauener H; Eichenberger E Psychopharmacologia; 1973 Feb; 28(4):325-37. PubMed ID: 4695567 [No Abstract] [Full Text] [Related]
11. Pharmacology of fluperlapine compared with clozapine. Eichenberger E Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425 [TBL] [Abstract][Full Text] [Related]
12. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation. Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229 [TBL] [Abstract][Full Text] [Related]
13. Antipsychotic efficacy of clozapine in correlation to changes in catecholamine metabolism in man. Ackenheil M; Beckmann H; Greil W; Hoffmann G; Markianos E; Raese J Adv Biochem Psychopharmacol; 1974; 9(0):647-57. PubMed ID: 4836227 [No Abstract] [Full Text] [Related]
15. Synthesis and biological activity of dibenz[c,e]azepines. Aboul-Enein HY; Ibrahim SE; Khalifa M Drug Des Deliv; 1989 Jan; 4(1):27-33. PubMed ID: 2775444 [TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents. Norman MH; Rigdon GC; Hall WR; Navas F J Med Chem; 1996 Mar; 39(5):1172-88. PubMed ID: 8676355 [TBL] [Abstract][Full Text] [Related]
17. Effects of some dibenzo-azepines on suppressed and nonsuppressed behavior of squirrel monkeys. Spealman RD Psychopharmacology (Berl); 1985; 85(2):129-32. PubMed ID: 2861615 [TBL] [Abstract][Full Text] [Related]
18. Analogues of morphanthridine and the tear gas dibenz[b,f][1,4]oxazepine (CR) as extremely potent activators of the human transient receptor potential ankyrin 1 (TRPA1) channel. Gijsen HJ; Berthelot D; Zaja M; Brône B; Geuens I; Mercken M J Med Chem; 2010 Oct; 53(19):7011-20. PubMed ID: 20806939 [TBL] [Abstract][Full Text] [Related]
19. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828 [TBL] [Abstract][Full Text] [Related]